Britta Liedigk

Prediction of Antibiotic Susceptibility Profiles of Vibrio cholerae Isolates From Whole Genome Illumina and Nanopore Sequencing Data: CholerAegon

M. Marz, D. Eibach, S. Herrera-León, 2022, Frontiers in Microbiology.

Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

Claudia Kohl, Andreas Nitsche, David A. Matthews, 2015, Nature.

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

P. Maes, S. Günther, Y. Yazdanpanah, 2016, PLoS medicine.

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

P. Maes, S. Ombelet, M. Bentahir, 2016, PLoS medicine.

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

P. Maes, S. Günther, Y. Yazdanpanah, 2016, PLoS medicine.

Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015

P. Formenty, H. Ellerbrok, P. Maes, 2016, The Journal of infectious diseases.

Ultrasensitive Monitoring of HIV-1 Viral Load by a Low-Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for the 5′ Long Terminal Repeat Domain

Christian Drosten, Jan Felix Drexler, Wolfgang Preiser, 2006, Clinical chemistry.